OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Mutant KRAS Drives Immune Evasion by Sensitizing Cytotoxic T‐Cells to Activation‐Induced Cell Death in Colorectal Cancer
Huashan Liu, Zhenxing Liang, Sijing Cheng, et al.
Advanced Science (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 28
Huashan Liu, Zhenxing Liang, Sijing Cheng, et al.
Advanced Science (2023) Vol. 10, Iss. 6
Open Access | Times Cited: 28
Showing 1-25 of 28 citing articles:
KRT17 Promotes T-lymphocyte Infiltration Through the YTHDF2–CXCL10 Axis in Colorectal Cancer
Wenfeng Liang, Huashan Liu, Ziwei Zeng, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 875-894
Open Access | Times Cited: 48
Wenfeng Liang, Huashan Liu, Ziwei Zeng, et al.
Cancer Immunology Research (2023) Vol. 11, Iss. 7, pp. 875-894
Open Access | Times Cited: 48
Exploiting the therapeutic implications of KRAS inhibition on tumor immunity
Míriam Molina‐Arcas, Julian Downward
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 338-357
Open Access | Times Cited: 46
Míriam Molina‐Arcas, Julian Downward
Cancer Cell (2024) Vol. 42, Iss. 3, pp. 338-357
Open Access | Times Cited: 46
Mutant KRAS-activated circATXN7 fosters tumor immunoescape by sensitizing tumor-specific T cells to activation-induced cell death
Chi Zhou, Wenxin Li, Liang Zhenxing, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
Chi Zhou, Wenxin Li, Liang Zhenxing, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 27
The emerging role of lactate in tumor microenvironment and its clinical relevance
Sihan Chen, Yining Xu, Wei Zhuo, et al.
Cancer Letters (2024) Vol. 590, pp. 216837-216837
Closed Access | Times Cited: 27
Sihan Chen, Yining Xu, Wei Zhuo, et al.
Cancer Letters (2024) Vol. 590, pp. 216837-216837
Closed Access | Times Cited: 27
Lactate and lactylation in cancer
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Jie Chen, Ziyue Huang, Ya Chen, et al.
Signal Transduction and Targeted Therapy (2025) Vol. 10, Iss. 1
Open Access | Times Cited: 6
Targeting KRAS: from metabolic regulation to cancer treatment
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Yanyan Shi, Huiling Zheng, Tianzhen Wang, et al.
Molecular Cancer (2025) Vol. 24, Iss. 1
Open Access | Times Cited: 3
Glycolysis in the tumor microenvironment: a driver of cancer progression and a promising therapeutic target
Junpeng Zhao, Dandan Jin, Mengxiang Huang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 13
Junpeng Zhao, Dandan Jin, Mengxiang Huang, et al.
Frontiers in Cell and Developmental Biology (2024) Vol. 12
Open Access | Times Cited: 13
Regorafenib plus sintilimab as a salvage treatment for microsatellite stable metastatic colorectal cancer: a single-arm, open-label, phase II clinical trial
Rui Liu, Zhi Ji, Xia Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Rui Liu, Zhi Ji, Xia Wang, et al.
Nature Communications (2025) Vol. 16, Iss. 1
Open Access | Times Cited: 1
Facts and Hopes on RAS Inhibitors and Cancer Immunotherapy
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Jesse Boumelha, Míriam Molina‐Arcas, Julian Downward
Clinical Cancer Research (2023) Vol. 29, Iss. 24, pp. 5012-5020
Open Access | Times Cited: 14
Anti‐Tumor Strategies Targeting Nutritional Deprivation: Challenges and Opportunities
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Jinsheng Shi, Wei Han, Jie Wang, et al.
Advanced Materials (2025)
Closed Access
Genome-wide CRISPR screening identifies PHF8 as an effective therapeutic target for KRAS- or BRAF-mutant colorectal cancers
Zhao Liu, Yiqi Li, Simeng Wang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Zhao Liu, Yiqi Li, Simeng Wang, et al.
Journal of Experimental & Clinical Cancer Research (2025) Vol. 44, Iss. 1
Open Access
Drugging the Undruggable and beyond: Emerging precision oncology approaches to target acquired resistance to KRAS G12C and KRAS G12D inhibitors
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Ramesh R. Kale, Charudatt Samant, Krishnadas Nandakumar, et al.
Biochemical and Biophysical Research Communications (2025), pp. 151688-151688
Closed Access
Oncogenic KRAS drives immunosuppression of colorectal cancer by impairing DDX60-mediated dsRNA accumulation and viral mimicry
Yi Zhou, Yaxin Zhang, Mingzhou Li, et al.
Science Immunology (2024) Vol. 9, Iss. 100
Closed Access | Times Cited: 4
Yi Zhou, Yaxin Zhang, Mingzhou Li, et al.
Science Immunology (2024) Vol. 9, Iss. 100
Closed Access | Times Cited: 4
Genomic instability as a driver and suppressor of anti-tumor immunity
Marta Requesens, Floris Foijer, Hans W. Nijman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Marta Requesens, Floris Foijer, Hans W. Nijman, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 2
Genetic Alterations of NF-κB and Its Regulators: A Rich Platform to Advance Colorectal Cancer Diagnosis and Treatment
Faranak Alipourgivi, Aishat Motolani, A. Qiu, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 154-154
Open Access | Times Cited: 6
Faranak Alipourgivi, Aishat Motolani, A. Qiu, et al.
International Journal of Molecular Sciences (2023) Vol. 25, Iss. 1, pp. 154-154
Open Access | Times Cited: 6
Bacterial lipopolysaccharide related genes signature as potential biomarker for prognosis and immune treatment in gastric cancer
Tianyi Yuan, Siming Zhang, Songnian He, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Tianyi Yuan, Siming Zhang, Songnian He, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 5
Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production
Junfan Wang, Xiao‐Jian Han, Yanan Hao, et al.
Cellular Immunology (2024) Vol. 403-404, pp. 104863-104863
Closed Access | Times Cited: 1
Junfan Wang, Xiao‐Jian Han, Yanan Hao, et al.
Cellular Immunology (2024) Vol. 403-404, pp. 104863-104863
Closed Access | Times Cited: 1
Case report: long-term sustained remission in a case of metastatic colon cancer with high microsatellite instability and KRAS exon 2 p.G12D mutation treated with fruquintinib after local radiotherapy: a case report and literature review
Ruiqi Wang, Dan Cong, Yuansong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Ruiqi Wang, Dan Cong, Yuansong Bai, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 2
Unraveling the Role of Ras Homolog Enriched in Brain (Rheb1 and Rheb2): Bridging Neuronal Dynamics and Cancer Pathogenesis through Mechanistic Target of Rapamycin Signaling
Mostafizur Rahman, Tuan Minh Nguyen, Gi Jeong Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1489-1489
Open Access
Mostafizur Rahman, Tuan Minh Nguyen, Gi Jeong Lee, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1489-1489
Open Access
Acetylation of ELMO1 correlates with Rac1 activity and colorectal cancer progress
Chuangkun Li, Jianmei Yi, Haiqing Jie, et al.
Experimental Cell Research (2024) Vol. 439, Iss. 1, pp. 114068-114068
Closed Access
Chuangkun Li, Jianmei Yi, Haiqing Jie, et al.
Experimental Cell Research (2024) Vol. 439, Iss. 1, pp. 114068-114068
Closed Access
LncRNA TMPO-AS1 Promotes Triple-Negative Breast Cancer by Sponging miR-383-5p to Trigger the LDHA Axis
Prerna Vats, Jay Singh, Sandeep Kumar Srivastava, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 8, pp. 2929-2944
Open Access
Prerna Vats, Jay Singh, Sandeep Kumar Srivastava, et al.
Asian Pacific Journal of Cancer Prevention (2024) Vol. 25, Iss. 8, pp. 2929-2944
Open Access
The Demographic Profile of Colorectal Cancer Patients in Indonesia: Insights from a Single Center Experience and Exploration of Immune Response and Survival Outcomes
Cosphiadi Irawan, Findy Prasetyawaty
F1000Research (2024) Vol. 13, pp. 1362-1362
Open Access
Cosphiadi Irawan, Findy Prasetyawaty
F1000Research (2024) Vol. 13, pp. 1362-1362
Open Access
Viral mimicry evasion: a new role for oncogenic KRAS mutations
Raymond Chen, Aobo He, Daniel D. De Carvalho
Molecular Oncology (2024)
Open Access
Raymond Chen, Aobo He, Daniel D. De Carvalho
Molecular Oncology (2024)
Open Access
The role of immune checkpoint inhibitors for patients with advanced stage microsatellite stable colorectal cancer and high tumor mutation burden: quantity or quality?
Charan Thej Reddy Vegivinti, Cyndi Gonzales Gomez, Masood Pasha Syed, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 595-601
Closed Access | Times Cited: 1
Charan Thej Reddy Vegivinti, Cyndi Gonzales Gomez, Masood Pasha Syed, et al.
Expert Opinion on Biological Therapy (2023) Vol. 23, Iss. 7, pp. 595-601
Closed Access | Times Cited: 1
